TY - JOUR AU - Alonso Miguel, Daniel AU - Valdivia Lara, Edgar Guillermo AU - García San José, Paula AU - Alonso Díez, Ángela AU - Clares, Irene AU - Portero Fuentes, Miriam AU - Peña Fernández, Laura Luisa AU - Pérez Alenza, María De Los Dolores PY - 2022 DO - 10.1111/vco.12760 SN - 1476-5810 UR - https://hdl.handle.net/20.500.14352/107253 T2 - Veterinary and Comparative Oncology AB - Canine inflammatory mammary cancer (IMC) is highly malignant, invasive and a therapeutic challenge, because effective medical treatment is still unavailable. This retrospective study compares the efficacy of an oral cyclooxygenase-2 (COX-2) inhibitor... LA - eng M2 - 179 PB - Wiley KW - Canine KW - COX-2 inhibitors KW - Inflammatory mammary cancer KW - Metronomic KW - Toceranib TI - Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase‐2 inhibitor and toceranib phosphate TY - journal article VL - 20 ER -